1. Deux nouveaux dérivés antitumoraux: l'hydroxy-9-méthyl-2 ellipticinium et l'hydroxy-9-diméthyl-2,6 ellipticinium;Le Pecq,1975
2. Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC-264137) in advanced human cancer;Juret;Eur J Cancer,1978
3. L'acétate d'hydroxy-9 méthyl-2 ellipticinium (NSC-264137);Juret,1979
4. Hydroxymethyl ellipticinium (NSC-264 137);Brugaloras,1979
5. Antitumor activity, pharmacology and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives;Paoletti,1980